Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Catechol O-Methyltransferase »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Catechin < Catechol O-Methyltransferase < Catechol O-Methyltransferase Inhibitors  Facettes :

List of bibliographic references indexed by Catechol O-Methyltransferase

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000C00 (2014) Cristina Nombela [Royaume-Uni] ; James B. Rowe [Royaume-Uni] ; Sophie E. Winder-Rhodes [Royaume-Uni] ; Adam Hampshire [Royaume-Uni] ; Adrian M. Owen [Canada] ; David P. Breen [Royaume-Uni] ; Gordon W. Duncan [Royaume-Uni] ; Tien K. Khoo [Australie] ; Alison J. Yarnall [Royaume-Uni] ; Michael J. Firbank [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] ; David J. Brooks [Royaume-Uni, Danemark] ; David J. Burn [Royaume-Uni] ; Roger A. Barker [Royaume-Uni]Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study
001C52 (2010) A. Jon Stoessl [Canada]Continuous dopaminergic therapy in Parkinson disease: Time to stride back?
002A81 (2005) Richard Camicioli [Canada] ; Ali Rajput [Canada] ; Michelle Rajput [Canada] ; Christian Reece [Canada] ; Haydeh Payami [États-Unis] ; Chunhai Hao [Canada] ; Alex Rajput [Canada]Apolipoprotein E ϵ4 and catechol‐O‐methyltransferase alleles in autopsy‐proven Parkinson's disease: Relationship to dementia and hallucinations
002A87 (2005) Guowei Huang [Canada, République populaire de Chine] ; Magdalena Dragan [Canada] ; David Freeman [Canada] ; John X. Wilson [Canada, États-Unis]Activation of catechol‐O‐methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons
002B79 (2004) Ronald B. Postuma [Canada] ; Anthony E. LangHomocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
002F65 (2002) Oksana Suchowersky [Canada]Parkinson's disease: medical treatment of moderate to advanced disease.
003865 (1998) A A Boulton [Canada] ; G. EisenhoferCatecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview.
003C61 (1997) D. J. Doudet [Canada] ; G. L. Y. Chan [Canada] ; J. E. Holden [États-Unis] ; K. S. Morrison [Canada] ; R. J. Wyatt [États-Unis] ; T. J. Ruth [Canada]Effects of catechol-O-methyltransferase inhibition on the rates of uptake and reversibility of 6-fluoro-L-dopa trapping in MPTP-induced Parkinsonism in monkeys
004E05 (1986) W. KalowEthnic differences in reactions to drugs and xenobiotics. Conjugation reactions.
005588 (????) D J Chong [Canada] ; O. Suchowersky ; C. Szumlanski ; R M Weinshilboum ; R. Brant ; N R CampbellThe relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Catechol O-Methyltransferase" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Catechol O-Methyltransferase" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Catechol O-Methyltransferase
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022